Logo image of HIVE.CA

HIVE DIGITAL TECHNOLOGIES LT (HIVE.CA) Stock Fundamental Analysis

TSX-V:HIVE - TSX Venture Exchange - CA4339211035 - Common Stock - Currency: CAD

2.9  +0.18 (+6.62%)

Fundamental Rating

4

Taking everything into account, HIVE scores 4 out of 10 in our fundamental rating. HIVE was compared to 66 industry peers in the Software industry. HIVE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, HIVE is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year HIVE has reported negative net income.
HIVE had a negative operating cash flow in the past year.
In multiple years HIVE reported negative net income over the last 5 years.
In the past 5 years HIVE always reported a positive cash flow from operatings.
HIVE.CA Yearly Net Income VS EBIT VS OCF VS FCFHIVE.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100M -200M

1.2 Ratios

The Return On Assets of HIVE (-1.38%) is better than 61.19% of its industry peers.
HIVE has a Return On Equity of -1.52%. This is in the better half of the industry: HIVE outperforms 64.18% of its industry peers.
Industry RankSector Rank
ROA -1.38%
ROE -1.52%
ROIC N/A
ROA(3y)-39.86%
ROA(5y)-22.35%
ROE(3y)-52.71%
ROE(5y)-29.43%
ROIC(3y)N/A
ROIC(5y)N/A
HIVE.CA Yearly ROA, ROE, ROICHIVE.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

1.3 Margins

HIVE does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HIVE.CA Yearly Profit, Operating, Gross MarginsHIVE.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

More info and screens

6

2. Health

2.1 Basic Checks

HIVE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for HIVE has been increased compared to 1 year ago.
HIVE has more shares outstanding than it did 5 years ago.
HIVE has a better debt/assets ratio than last year.
HIVE.CA Yearly Shares OutstandingHIVE.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
HIVE.CA Yearly Total Debt VS Total AssetsHIVE.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

An Altman-Z score of 4.00 indicates that HIVE is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 4.00, HIVE is doing good in the industry, outperforming 67.16% of the companies in the same industry.
HIVE has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
HIVE has a Debt to Equity ratio of 0.04. This is in the better half of the industry: HIVE outperforms 73.13% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z 4
ROIC/WACCN/A
WACC11.53%
HIVE.CA Yearly LT Debt VS Equity VS FCFHIVE.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

2.3 Liquidity

A Current Ratio of 10.41 indicates that HIVE has no problem at all paying its short term obligations.
HIVE has a better Current ratio (10.41) than 92.54% of its industry peers.
A Quick Ratio of 10.41 indicates that HIVE has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 10.41, HIVE belongs to the top of the industry, outperforming 92.54% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 10.41
Quick Ratio 10.41
HIVE.CA Yearly Current Assets VS Current LiabilitesHIVE.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 84.85% over the past year.
Looking at the last year, HIVE shows a very strong growth in Revenue. The Revenue has grown by 26.29%.
Measured over the past years, HIVE shows a very strong growth in Revenue. The Revenue has been growing by 29.18% on average per year.
EPS 1Y (TTM)84.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
Revenue 1Y (TTM)26.29%
Revenue growth 3Y19.73%
Revenue growth 5Y29.18%
Sales Q2Q%-6.47%

3.2 Future

HIVE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.81% yearly.
Based on estimates for the next years, HIVE will show a quite strong growth in Revenue. The Revenue will grow by 13.66% on average per year.
EPS Next Y58.41%
EPS Next 2Y24.54%
EPS Next 3Y41.81%
EPS Next 5YN/A
Revenue Next Year3.46%
Revenue Next 2Y70.08%
Revenue Next 3Y13.66%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
HIVE.CA Yearly Revenue VS EstimatesHIVE.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
HIVE.CA Yearly EPS VS EstimatesHIVE.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 -2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

HIVE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for HIVE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HIVE.CA Price Earnings VS Forward Price EarningsHIVE.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -18.34
HIVE.CA Per share dataHIVE.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

HIVE's earnings are expected to grow with 41.81% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.54%
EPS Next 3Y41.81%

More info and screens

0

5. Dividend

5.1 Amount

HIVE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HIVE DIGITAL TECHNOLOGIES LT

TSX-V:HIVE (3/7/2025, 7:00:00 PM)

2.9

+0.18 (+6.62%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-11 2025-02-11/amc
Earnings (Next)06-23 2025-06-23/bmo
Inst Owners23.92%
Inst Owner ChangeN/A
Ins Owners0.42%
Ins Owner ChangeN/A
Market Cap458.46M
Analysts80
Price Target8.33 (187.24%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)44.71%
Min EPS beat(2)43.42%
Max EPS beat(2)45.99%
EPS beat(4)4
Avg EPS beat(4)57.78%
Min EPS beat(4)43.42%
Max EPS beat(4)93.17%
EPS beat(8)6
Avg EPS beat(8)35.78%
EPS beat(12)7
Avg EPS beat(12)-166.51%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.56%
Min Revenue beat(2)-8.08%
Max Revenue beat(2)9.21%
Revenue beat(4)3
Avg Revenue beat(4)5.87%
Min Revenue beat(4)-8.08%
Max Revenue beat(4)17.08%
Revenue beat(8)6
Avg Revenue beat(8)4.84%
Revenue beat(12)9
Avg Revenue beat(12)18.48%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)8.89%
PT rev (3m)10.84%
EPS NQ rev (1m)0%
EPS NQ rev (3m)11.11%
EPS NY rev (1m)14.29%
EPS NY rev (3m)22.22%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)5.59%
Revenue NY rev (1m)5.74%
Revenue NY rev (3m)4.26%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.64
P/FCF N/A
P/OCF N/A
P/B 0.74
P/tB 0.74
EV/EBITDA -18.34
EPS(TTM)-0.14
EYN/A
EPS(NY)-0.33
Fwd EYN/A
FCF(TTM)-1.15
FCFYN/A
OCF(TTM)-0.39
OCFYN/A
SpS1.1
BVpS3.94
TBVpS3.94
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.38%
ROE -1.52%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-39.86%
ROA(5y)-22.35%
ROE(3y)-52.71%
ROE(5y)-29.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA 1.22
Cap/Depr 126.51%
Cap/Sales 68.63%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 10.41
Quick Ratio 10.41
Altman-Z 4
F-Score3
WACC11.53%
ROIC/WACCN/A
Cap/Depr(3y)132.64%
Cap/Depr(5y)N/A
Cap/Sales(3y)51.57%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)84.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
EPS Next Y58.41%
EPS Next 2Y24.54%
EPS Next 3Y41.81%
EPS Next 5YN/A
Revenue 1Y (TTM)26.29%
Revenue growth 3Y19.73%
Revenue growth 5Y29.18%
Sales Q2Q%-6.47%
Revenue Next Year3.46%
Revenue Next 2Y70.08%
Revenue Next 3Y13.66%
Revenue Next 5YN/A
EBIT growth 1Y-12.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year167.19%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-59.39%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-169.13%
OCF growth 3Y-17.04%
OCF growth 5YN/A